HaLCon Protein Analyzer: Purpose-built Liquid Chromatography System for Bioprocessing

Monoclonal Antibody Manufacturing Trends, Challenges, and Analytical Solutions to Eliminate Bioprocessing Bottlenecks
This infographic was originally published in the eBook
Monoclonal Antibody Manufacturing Trends, Challenges, and Analytical Solutions to Eliminate Bioprocessing Bottlenecks.  You can download all the articles in the series, by downloading the eBook.

Biologics, such as monoclonal antibodies and therapeutic proteins, have revolutionized healthcare by offering treatments for various diseases. Their significance will grow further with the rise of targeted and personalized therapies. To meet this demand, innovation in biomanufacturing is crucial, focusing on improving productivity and cost-efficiency for broader patient access. Regulatory agencies encourage Quality by Design (QbD) and Process Analytical Technology (PAT) to optimize processes like upstream bioprocessing and continuous bioprocessing. These approaches identify and control critical process parameters to enhance productivity and maintain quality standards.

However, traditional methods like High-Performance Liquid Chromatography (HPLC) face challenges in a production environment due to their size and complexity. This leads to delays in obtaining crucial data for downstream processes. The HaLCon Protein Analyzer by RedShiftBio addresses these challenges, offering a compact, easy-to-use solution for protein titer measurement in real-time. Its purpose-built design streamlines workflow, minimizes maintenance, and provides accurate results with minimal sample manipulation.

The HaLCon Analyzer’s performance has been validated through various studies, demonstrating its ability to generate exceptional titer data comparable to traditional HPLC instruments. Its real-time capabilities support efficient decision-making, enhance process control, and contribute to cost savings in bioprocessing. This innovation represents a significant step towards meeting the evolving needs of the biopharmaceutical industry for faster, more efficient drug development.

This infographic was originally published in the eBook
Monoclonal Antibody Manufacturing Trends, Challenges, and Analytical Solutions to Eliminate Bioprocessing Bottlenecks.

You can download all the articles in the series, by downloading the eBook.

Pin It on Pinterest